Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 2 feeds behind: Insider filings, 6 days, and 1 more · Every feed →
ACRV · 13 trades
Trades
13
Buys 0 · Sells 13
People
7
Stocks
1
Disclosed value
$74.8K
range midpoints · Congress & executive
Filed late
0
- ▼ SELLMary Miller Chief Legal OfficerACRV Acrivon Therapeutics, Inc.$585disclosed Oct 7 · filed 2 days after the trade
- ▼ SELLKristina Masson EVP - Business OperationsACRV Acrivon Therapeutics, Inc.$31Kdisclosed Aug 27 · filed 2 days after the trade
- ▼ SELLPeter Blume-Jensen President and CEOACRV Acrivon Therapeutics, Inc.$31Kdisclosed Aug 27 · filed 2 days after the trade
- ▼ SELLPeter Blume-Jensen President and CEOACRV Acrivon Therapeutics, Inc.$973disclosed Aug 20 · filed 2 days after the trade
- ▼ SELLEric Devroe Chief Operating OfficerACRV Acrivon Therapeutics, Inc.$1.2Kdisclosed Aug 20 · filed 2 days after the trade
- ▼ SELLKristina Masson EVP - Business OperationsACRV Acrivon Therapeutics, Inc.$973disclosed Aug 20 · filed 2 days after the trade
- ▼ SELLPeter Blume-Jensen President and CEOACRV Acrivon Therapeutics, Inc.$2.5Kdisclosed Aug 20 · filed 2 days after the trade
- ▼ SELLKristina Masson EVP - Business OperationsACRV Acrivon Therapeutics, Inc.$2.5Kdisclosed Aug 20 · filed 2 days after the trade
- ▼ SELLKatharine Peterson Chief Accounting OfficerACRV Acrivon Therapeutics, Inc.$203disclosed Aug 20 · filed 2 days after the trade
- ▼ SELLMary Miller Chief Legal OfficerACRV Acrivon Therapeutics, Inc.$372disclosed Aug 20 · filed 2 days after the trade
- ▼ SELLErick Gamelin Chief Development OfficerACRV Acrivon Therapeutics, Inc.$804disclosed Aug 20 · filed 2 days after the trade
- ▼ SELLAdam D. Levy Chief Financial OfficerACRV Acrivon Therapeutics, Inc.$1.8Kdisclosed Aug 6 · filed 2 days after the trade
- ▼ SELLMary Miller Chief Legal OfficerACRV Acrivon Therapeutics, Inc.$1Kdisclosed Jul 23 · filed 2 days after the trade